Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center. In this video series, the doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. This next panel discussion is regarding progression after success on an ALK inhibitor. Do you continue the ALK inhibitor when transitioning to a chemo based treatment?

Please feel free to offer comments and raise questions in our
discussion forums.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.
Since your doctor didn't seem too worried...